Source: EURLEX
Language: en
Format: md

|  |  |  |
| --- | --- | --- |
| European flag | Official Journal  of the European Union | EN  Series C |

---

|  |  |  |
| --- | --- | --- |
|  | C/2023/69 | 9.10.2023 |

Action brought on 22 August 2023 — Hecht Pharma v EUIPO — Gufic BioSciences (H 15 Gufic H 15 Gufic)

(Case T-520/23)

(C/2023/69)

Language in which the application was lodged: German

Parties

Applicant: Hecht Pharma GmbH (Bremervörde, Germany) (represented by: C. Sachs and J. Sachs, lawyers)

Defendant: European Union Intellectual Property Office

Other party to the proceedings before the Board of Appeal: Gufic BioSciences Ltd. (Mumbai, India)

Details of the proceedings before EUIPO

Proprietor of the trade mark at issue: Other party to the proceedings before the Board of Appeal

Trade mark at issue: EU figurative mark H 15 Gufic H 15 Gufic — EU trade mark No 8 285 661

Proceedings before EUIPO: Cancellation proceedings

Contested decision: Decision of the Second Board of Appeal of EUIPO of 13 June 2023 in Case R 902/2021-2

Form of order sought

The applicant claims that the Court should:

|  |  |
| --- | --- |
| — | annul the contested decision and declare the trade mark at issue to be revoked also in respect of Class 5 ‘Medicines’; |

|  |  |
| --- | --- |
| — | order EUIPO to pay the costs of the appeal proceedings and of the pre-litigation procedure. |

Plea in law

|  |  |
| --- | --- |
| — | Infringement of Article 58(1) of Regulation (EU) 2017/1001 of the European Parliament and of the Council. |

---

[Top](#document1)